Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted March 20, 2016
FDA Warns of Weight Supplements Containing Undeclared Drugs
- Eradicate Capsules were found to contain sibutramine and desmethylsibutramine.
- Xerophagy Capsules were found to contain sibutramine.
- Dynamizm Capsules were found to contain sibutramine.
- ZlimXter Capsules were found to contain sildenafil.
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking. Desmethylsiburamine is similar to sibutramine.
Sildenafil is the active ingredient in Viagra, which is prescribed for erectile dysfunction. This drug can cause symptoms like headache and flushing, and can interact with medications containing nitrates such as nitroglycerine, resulting in dangerously low blood pressure.
Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.
See Related Warnings:
For more recalls and warnings, use the link below.